
    
      This is a prospective, double-blind, placebo controlled, clinical trial examining vascular
      effects of allopurinol in patients who received a kidney transplant that are maintaining
      stable renal function for at least 1 year. End-points include pulse-wave velocity, systemic
      blood pressure and kidney function among others.
    
  